Page last updated: 2024-10-24

celiprolol and Reperfusion Injury

celiprolol has been researched along with Reperfusion Injury in 1 studies

Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research Excerpts

ExcerptRelevanceReference
"Ischemic acute renal failure is associated with vascular endothelial dysfunction."1.31Effects of vasodilatory antihypertensive agents on endothelial dysfunction in rats with ischemic acute renal failure. ( Goto, A; Hayakawa, H; Hirata, Y; Kakoki, M; Kimura, K; Nagata, D; Nishimatsu, H; Omata, M; Suzuki, E, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kakoki, M1
Hirata, Y1
Hayakawa, H1
Suzuki, E1
Nagata, D1
Nishimatsu, H1
Kimura, K1
Goto, A1
Omata, M1

Other Studies

1 other study available for celiprolol and Reperfusion Injury

ArticleYear
Effects of vasodilatory antihypertensive agents on endothelial dysfunction in rats with ischemic acute renal failure.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2000, Volume: 23, Issue:5

    Topics: Acetylcholine; Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertens

2000